Professor Bunnett is one of the world’s
leading experts in gastrointestinal diseases
and disorders. He received his PhD degree
from the University of Cambridge, spent
most of his career at the University of
California, San Francisco, and joined
MIPS in 2011.
With several gastrointestinal diseases
and disorders in humans poorly
understood and inadequately treated,
MIPS and Takeda Pharmaceutical
Company Limited have signed a
new strategic research alliance to
develop new medicines to address
significant unmet medical needs in
gastroenterology.
Irritable bowel syndrome, abdominal pain,
chronic itch, severe constipation and diarrhoea are
examples of some of the common and debilitating
disorders that afflict millions of people worldwide
and that will be the focus of the research alliance.
Funding from Takeda will enable MIPS and
Takeda scientists to work together to research
the mechanisms that underlie these diseases and
develop new and highly innovative approaches for
their treatment.
20